Literature DB >> 29734484

Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.

Rakesh Shiradkar1, Soumya Ghose1, Ivan Jambor2,3, Pekka Taimen4,5, Otto Ettala6, Andrei S Purysko7, Anant Madabhushi1.   

Abstract

BACKGROUND: Radiomics or computer-extracted texture features derived from MRI have been shown to help quantitatively characterize prostate cancer (PCa). Radiomics have not been explored depth in the context of predicting biochemical recurrence (BCR) of PCa.
PURPOSE: To identify a set of radiomic features derived from pretreatment biparametric MRI (bpMRI) that may be predictive of PCa BCR. STUDY TYPE: Retrospective.
SUBJECTS: In all, 120 PCa patients from two institutions, I1 and I2 , partitioned into training set D1 (N = 70) from I1 and independent validation set D2 (N = 50) from I2 . All patients were followed for ≥3 years. SEQUENCE: 3T, T2 -weighted (T2 WI) and apparent diffusion coefficient (ADC) maps derived from diffusion-weighted sequences. ASSESSMENT: PCa regions of interest (ROIs) on T2 WI were annotated by two experienced radiologists. Radiomic features from bpMRI (T2 WI and ADC maps) were extracted from the ROIs. A machine-learning classifier (CBCR ) was trained with the best discriminating set of radiomic features to predict BCR (pBCR ). STATISTICAL TESTS: Wilcoxon rank-sum tests with P < 0.05 were considered statistically significant. Differences in BCR-free survival at 3 years using pBCR was assessed using the Kaplan-Meier method and compared with Gleason Score (GS), PSA, and PIRADS-v2.
RESULTS: Distribution statistics of co-occurrence of local anisotropic gradient orientation (CoLlAGe) and Haralick features from T2 WI and ADC were associated with BCR (P < 0.05) on D1 . CBCR predictions resulted in a mean AUC = 0.84 on D1 and AUC = 0.73 on D2 . A significant difference in BCR-free survival between the predicted classes (BCR + and BCR-) was observed (P = 0.02) on D2 compared to those obtained from GS (P = 0.8), PSA (P = 0.93) and PIRADS-v2 (P = 0.23). DATA
CONCLUSION: Radiomic features from pretreatment bpMRI can be predictive of PCa BCR after therapy and may help identify men who would benefit from adjuvant therapy. LEVEL OF EVIDENCE: 4 Technical Efficacy: Stage 5 J. Magn. Reson. Imaging 2018;48:1626-1636.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  computer-assisted image processing; magnetic resonance imaging; projections and predictions; prostate cancer; recurrence

Mesh:

Year:  2018        PMID: 29734484      PMCID: PMC6222024          DOI: 10.1002/jmri.26178

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  28 in total

1.  Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer.

Authors:  Patrick A Kupelian; Arul Mahadevan; Chandana A Reddy; Alwyn M Reuther; Eric A Klein
Journal:  Urology       Date:  2006-09-18       Impact factor: 2.649

2.  Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.

Authors:  Stephen J Freedland; Elizabeth B Humphreys; Leslie A Mangold; Mario Eisenberger; Frederick J Dorey; Patrick C Walsh; Alan W Partin
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

Review 3.  Computer-Aided Detection and diagnosis for prostate cancer based on mono and multi-parametric MRI: a review.

Authors:  Guillaume Lemaître; Robert Martí; Jordi Freixenet; Joan C Vilanova; Paul M Walker; Fabrice Meriaudeau
Journal:  Comput Biol Med       Date:  2015-02-20       Impact factor: 4.589

4.  Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery.

Authors:  Satish E Viswanath; Nicholas B Bloch; Jonathan C Chappelow; Robert Toth; Neil M Rofsky; Elizabeth M Genega; Robert E Lenkinski; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2012-02-15       Impact factor: 4.813

5.  Computer-aided detection of prostate cancer in MRI.

Authors:  Geert Litjens; Oscar Debats; Jelle Barentsz; Nico Karssemeijer; Henkjan Huisman
Journal:  IEEE Trans Med Imaging       Date:  2014-05       Impact factor: 10.048

6.  Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images.

Authors:  Duc Fehr; Harini Veeraraghavan; Andreas Wibmer; Tatsuo Gondo; Kazuhiro Matsumoto; Herbert Alberto Vargas; Evis Sala; Hedvig Hricak; Joseph O Deasy
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

7.  Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.

Authors:  Jochen Walz; Felix K-H Chun; Eric A Klein; Alwyn Reuther; Fred Saad; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Journal:  J Urol       Date:  2008-12-13       Impact factor: 7.450

Review 8.  Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.

Authors:  John V Hegde; Robert V Mulkern; Lawrence P Panych; Fiona M Fennessy; Andriy Fedorov; Stephan E Maier; Clare M C Tempany
Journal:  J Magn Reson Imaging       Date:  2013-05       Impact factor: 4.813

9.  Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy--initial experience.

Authors:  David A McKenna; Fergus V Coakley; Antonio C Westphalen; Shoujun Zhao; Ying Lu; Emily M Webb; Barby Pickett; Mack Roach; John Kurhanewicz
Journal:  Radiology       Date:  2008-02-07       Impact factor: 11.105

10.  Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe): A new radiomics descriptor.

Authors:  Prateek Prasanna; Pallavi Tiwari; Anant Madabhushi
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

View more
  36 in total

Review 1.  Potentials of radiomics for cancer diagnosis and treatment in comparison with computer-aided diagnosis.

Authors:  Hidetaka Arimura; Mazen Soufi; Kenta Ninomiya; Hidemi Kamezawa; Masahiro Yamada
Journal:  Radiol Phys Technol       Date:  2018-10-29

2.  Sexually dimorphic radiogenomic models identify distinct imaging and biological pathways that are prognostic of overall survival in glioblastoma.

Authors:  Niha Beig; Salendra Singh; Kaustav Bera; Prateek Prasanna; Gagandeep Singh; Jonathan Chen; Anas Saeed Bamashmos; Addison Barnett; Kyle Hunter; Volodymyr Statsevych; Virginia B Hill; Vinay Varadan; Anant Madabhushi; Manmeet S Ahluwalia; Pallavi Tiwari
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

Review 3.  The role of radiomics in prostate cancer radiotherapy.

Authors:  Rodrigo Delgadillo; John C Ford; Matthew C Abramowitz; Alan Dal Pra; Alan Pollack; Radka Stoyanova
Journal:  Strahlenther Onkol       Date:  2020-08-21       Impact factor: 3.621

4.  Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings.

Authors:  Andrei S Purysko; Cristina Magi-Galluzzi; Omar Y Mian; Sarah Sittenfeld; Elai Davicioni; Marguerite du Plessis; Christine Buerki; Jennifer Bullen; Lin Li; Anant Madabhushi; Andrew Stephenson; Eric A Klein
Journal:  Eur Radiol       Date:  2019-03-07       Impact factor: 5.315

5.  A radiomics pipeline dedicated to Breast MRI: validation on a multi-scanner phantom study.

Authors:  Marie-Judith Saint Martin; Fanny Orlhac; Pia Akl; Fahad Khalid; Christophe Nioche; Irène Buvat; Caroline Malhaire; Frédérique Frouin
Journal:  MAGMA       Date:  2020-11-12       Impact factor: 2.310

6.  Radiomic Features of Primary Rectal Cancers on Baseline T2 -Weighted MRI Are Associated With Pathologic Complete Response to Neoadjuvant Chemoradiation: A Multisite Study.

Authors:  Jacob T Antunes; Asya Ofshteyn; Kaustav Bera; Erik Y Wang; Justin T Brady; Joseph E Willis; Kenneth A Friedman; Eric L Marderstein; Matthew F Kalady; Sharon L Stein; Andrei S Purysko; Rajmohan Paspulati; Jayakrishna Gollamudi; Anant Madabhushi; Satish E Viswanath
Journal:  J Magn Reson Imaging       Date:  2020-03-26       Impact factor: 4.813

7.  Imaging-Based Individualized Response Prediction Of Carbon Ion Radiotherapy For Prostate Cancer Patients.

Authors:  Shuang Wu; Yining Jiao; Yafang Zhang; Xuhua Ren; Ping Li; Qi Yu; Qing Zhang; Qian Wang; Shen Fu
Journal:  Cancer Manag Res       Date:  2019-10-24       Impact factor: 3.989

8.  Repeatability of radiomics and machine learning for DWI: Short-term repeatability study of 112 patients with prostate cancer.

Authors:  Harri Merisaari; Pekka Taimen; Rakesh Shiradkar; Otto Ettala; Marko Pesola; Jani Saunavaara; Peter J Boström; Anant Madabhushi; Hannu J Aronen; Ivan Jambor
Journal:  Magn Reson Med       Date:  2019-11-08       Impact factor: 4.668

9.  Development and validation of a multiparametric MRI-based radiomics signature for distinguishing between indolent and aggressive prostate cancer.

Authors:  Liuhui Zhang; Donggen Jiang; Chujie Chen; Xiangwei Yang; Hanqi Lei; Zhuang Kang; Hai Huang; Jun Pang
Journal:  Br J Radiol       Date:  2021-09-29       Impact factor: 3.039

10.  Reproducibility analysis of multi-institutional paired expert annotations and radiomic features of the Ivy Glioblastoma Atlas Project (Ivy GAP) dataset.

Authors:  Sarthak Pati; Ruchika Verma; Hamed Akbari; Michel Bilello; Virginia B Hill; Chiharu Sako; Ramon Correa; Niha Beig; Ludovic Venet; Siddhesh Thakur; Prashant Serai; Sung Min Ha; Geri D Blake; Russell Taki Shinohara; Pallavi Tiwari; Spyridon Bakas
Journal:  Med Phys       Date:  2020-12-04       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.